Bruna Karina Banin Hirata

CC Chemokine Receptor 5: The Interface of Host Immunity and Cancer

M. Watanabe, C. D. de Oliveira, J. Oda, 2014, Disease markers.

Molecular Markers for Breast Cancer: Prediction on Tumor Behavior

M. Watanabe, C. D. de Oliveira, J. Oda, 2014, Disease markers.

HER2 Ile655Val polymorphism is negatively associated with breast cancer susceptibility

M. Watanabe, J. Oda, R. Losi Guembarovski, 2018, Journal of clinical laboratory analysis.

Genetic Polymorphism and Expression of CXCR4 in Breast Cancer

M. Watanabe, C. D. de Oliveira, R. Losi Guembarovski, 2015, Analytical cellular pathology.

FOXP3 Allelic Variants and Haplotype Structures Are Associated with Aggressive Breast Cancer Subtypes

M. Watanabe, R. Losi Guembarovski, Bruna Karina Banin Hirata, 2017, Disease markers.

TGFβ1 pathway components in breast cancer tissue from aggressive subtypes correlate with better prognostic parameters in ER-positive and p53-negative cancers

Roberta Losi Guembarovski, M. Watanabe, Bruna Karina Banin Hirata, 2021, Surgical and Experimental Pathology.

Glutathione S-transferases deletions may act as prognosis and therapeutic markers in breast cancer

M. Watanabe, T. L. Mazzuco, R. Losi Guembarovski, 2018, Clinical and Experimental Medicine.

Glutathione S-transferases deletions may act as prognosis and therapeutic markers in breast cancer

M. Watanabe, T. L. Mazzuco, R. Losi Guembarovski, 2018, Clinical and Experimental Medicine.